These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7012337)

  • 1. Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.
    Stall KE; Martin EW
    J Reprod Med; 1981 Feb; 26(2):73-9. PubMed ID: 7012337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
    Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
    Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of plasma carcinoembryonic antigen (CEA) in patients with head and neck cancer: correlation with tissue CEA staining].
    Kawasaki T; Nagamine T; Suzuki I; Shingaki S; Nakajima T; Suzuki M
    Gan No Rinsho; 1986 Feb; 32(2):133-40. PubMed ID: 2421023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
    Meenakshi A; Kumar NS; Vijayshanker SG
    Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(44):388-92. PubMed ID: 11995458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
    Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of carcinoembryonic antigen in colorectal malignancy.
    Mazumdar A; Verma GR; Bose SM; Ganguly NK
    Trop Gastroenterol; 1999; 20(3):107-10. PubMed ID: 10695415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of diagnostic significance of carbohydrate antigen CA125 and cancer-embryonal antigen in ovarian cancer].
    Lapchenkov VI; Dudarev AL; Vinokurov VL; Iurkova LE; Barbanel EIu
    Vestn Rentgenol Radiol; 1993; (5):30-1. PubMed ID: 7801580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen.
    Chu CY; Lai LT; Pokala HP
    J Natl Cancer Inst; 1982 Jan; 68(1):75-9. PubMed ID: 7033631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.